Vanguard Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$161M Buy
4,906,218
+191,847
+4% +$6.29M ﹤0.01% 1612
2025
Q1
$152M Buy
4,714,371
+61,166
+1% +$1.97M ﹤0.01% 1606
2024
Q4
$142M Sell
4,653,205
-6,576
-0.1% -$201K ﹤0.01% 1698
2024
Q3
$131M Buy
4,659,781
+37,848
+0.8% +$1.06M ﹤0.01% 1753
2024
Q2
$105M Sell
4,621,933
-131,052
-3% -$2.98M ﹤0.01% 1811
2024
Q1
$145M Sell
4,752,985
-13,044
-0.3% -$397K ﹤0.01% 1680
2023
Q4
$170M Buy
4,766,029
+76,146
+2% +$2.72M ﹤0.01% 1598
2023
Q3
$205M Buy
4,689,883
+43,431
+0.9% +$1.9M 0.01% 1415
2023
Q2
$229M Buy
4,646,452
+113,635
+3% +$5.61M 0.01% 1406
2023
Q1
$188M Buy
4,532,817
+143,002
+3% +$5.93M ﹤0.01% 1480
2022
Q4
$195M Buy
4,389,815
+95,352
+2% +$4.23M 0.01% 1448
2022
Q3
$168M Buy
4,294,463
+6,613
+0.2% +$259K ﹤0.01% 1490
2022
Q2
$175M Buy
4,287,850
+28,486
+0.7% +$1.16M ﹤0.01% 1508
2022
Q1
$280M Buy
4,259,364
+25,066
+0.6% +$1.65M 0.01% 1333
2021
Q4
$294M Buy
4,234,298
+49,371
+1% +$3.43M 0.01% 1361
2021
Q3
$291M Sell
4,184,927
-11,287
-0.3% -$785K 0.01% 1344
2021
Q2
$333M Buy
4,196,214
+819,636
+24% +$65M 0.01% 1263
2021
Q1
$221M Buy
3,376,578
+956,111
+40% +$62.6M 0.01% 1528
2020
Q4
$135M Buy
2,420,467
+181,195
+8% +$10.1M ﹤0.01% 1678
2020
Q3
$89.3M Sell
2,239,272
-28,896
-1% -$1.15M ﹤0.01% 1743
2020
Q2
$102M Buy
2,268,168
+223,748
+11% +$10.1M ﹤0.01% 1669
2020
Q1
$68.7M Buy
2,044,420
+62,301
+3% +$2.09M ﹤0.01% 1713
2019
Q4
$64.4M Buy
1,982,119
+61,299
+3% +$1.99M ﹤0.01% 1977
2019
Q3
$47.9M Buy
1,920,820
+45,622
+2% +$1.14M ﹤0.01% 2092
2019
Q2
$56M Buy
1,875,198
+46,010
+3% +$1.37M ﹤0.01% 2037
2019
Q1
$49M Buy
1,829,188
+25,776
+1% +$691K ﹤0.01% 2092
2018
Q4
$55.2M Buy
1,803,412
+214,838
+14% +$6.57M ﹤0.01% 1980
2018
Q3
$55.6M Buy
1,588,574
+63,261
+4% +$2.22M ﹤0.01% 2089
2018
Q2
$41.3M Buy
1,525,313
+16,890
+1% +$457K ﹤0.01% 2229
2018
Q1
$31M Buy
1,508,423
+18,467
+1% +$379K ﹤0.01% 2324
2017
Q4
$27.2M Buy
1,489,956
+21,834
+1% +$398K ﹤0.01% 2368
2017
Q3
$32.8M Buy
1,468,122
+21,390
+1% +$478K ﹤0.01% 2263
2017
Q2
$35.1M Buy
1,446,732
+52,761
+4% +$1.28M ﹤0.01% 2197
2017
Q1
$26.7M Buy
1,393,971
+75,266
+6% +$1.44M ﹤0.01% 2315
2016
Q4
$25.8M Buy
1,318,705
+31,209
+2% +$611K ﹤0.01% 2308
2016
Q3
$20.4M Buy
1,287,496
+71,386
+6% +$1.13M ﹤0.01% 2352
2016
Q2
$17.2M Buy
1,216,110
+84,953
+8% +$1.2M ﹤0.01% 2395
2016
Q1
$19M Buy
1,131,157
+95,627
+9% +$1.61M ﹤0.01% 2323
2015
Q4
$23.2M Buy
1,035,530
+61,187
+6% +$1.37M ﹤0.01% 2242
2015
Q3
$21.3M Buy
974,343
+59,676
+7% +$1.31M ﹤0.01% 2265
2015
Q2
$22.5M Buy
914,667
+88,831
+11% +$2.19M ﹤0.01% 2299
2015
Q1
$16.9M Buy
825,836
+85,138
+11% +$1.74M ﹤0.01% 2397
2014
Q4
$14.8M Buy
740,698
+53,243
+8% +$1.06M ﹤0.01% 2381
2014
Q3
$10.1M Buy
687,455
+32,346
+5% +$476K ﹤0.01% 2489
2014
Q2
$12M Buy
655,109
+6,883
+1% +$127K ﹤0.01% 2431
2014
Q1
$12.2M Buy
648,226
+127,160
+24% +$2.39M ﹤0.01% 2395
2013
Q4
$9.73M Buy
521,066
+13,959
+3% +$261K ﹤0.01% 2475
2013
Q3
$5.57M Buy
507,107
+67,202
+15% +$738K ﹤0.01% 2679
2013
Q2
$4.18M Buy
+439,905
New +$4.18M ﹤0.01% 2762